30 Years of Groundbreaking Science, Training, and Innovation

Satellite Programs

Antithrombotic Management in TAVR With Atrial Fibrillation

Breakfast Program

09/23/2018 07:00:00 09/23/2018 08:00:00 Antithrombotic Management in TAVR With Atrial Fibrillation TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Breakfast Program

Sunday, September 23, 2018
Breakfast: 6:30 am  | 
Program: 7:00 am-8:00 am
San Diego Convention Center, 26A-B

Antithrombotic Management in TAVR With Atrial Fibrillation

Antithrombotic Management in TAVR With Atrial Fibrillation

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Daiichi Sankyo, Inc.

Chair  

George D. Dangas, MD, PhD

The Mount Sinai Hospital

New York, NY

Faculty  

Raj Makkar, MD

Cedars-Sinai Medical Center

Los Angeles, CA

 

Josep Rodes-Cabau, MD

Quebec Heart and Lung Institute/Laval University

Quebec, Canada

Agenda

7:00 am

Atrial Fibrillation (AF) in TAVR: Not Just an Innocent Bystander

Josep Rodes-Cabau

7:20 am

What is the Rationale for DOAC in TAVR With AF?

George D. Dangas

7:32 am

Leaflet Thrombosis After AVR: Is (D)OAC the Answer?

Raj Makkar

7:44 am

Panel Discussion

7:56 am

Adjourn